![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 19, 13167-13175, May 7, 1999
From Biogen, Inc., Cambridge, Massachusetts 02142
We have used the highly specific
Multiple Activation States of Integrin
4
1 Detected through Their Different
Affinities for a Small Molecule Ligand
4
1 inhibitor
4-((N'-2-methylphenyl)ureido)-phenylacetyl-leucine-aspartic
acid-valine-proline (BIO1211) as a model LDV-containing ligand to study
4
1 integrin-ligand interactions on Jurkat
cells under diverse conditions that affect the activation state of
4
1. Observed KD
values for BIO1211 binding ranged from a value of 20-40 nM
in the non-activated state of the integrin that exists in 1 mM Mg2+, 1 mM Ca2+ to
100 pM in the activated state seen in 2 mM
Mn2+ to 18 pM when binding was measured after
co-activation by 2 mM Mn2+ plus 10 µg/ml of
the integrin-activating monoclonal antibody TS2/16. The large range in
KD values was governed almost exclusively by
differences in the dissociation rates of the integrin-BIO1211 complex,
which ranged from 0.17 × 10
4 s
1 to
>140 × 10
4 s
1. Association rate
constants varied only slightly under the same conditions, all falling
in the narrow range from 0.9 to 2.7 × 106
M
1 s
1. The further increase in
affinity observed upon co-activation by divalent cations and TS2/16
compared with that observed at saturating concentrations of metal ions
or TS2/16 alone indicates that the mechanism by which these factors
bring about activation are distinct and identified a previously
unrecognized high affinity state on
4
1
that had not been detected by conventional assay methods. Similar
changes in affinity were observed when the binding properties of
vascular cell adhesion molecule-1 and CS1 to
4
1 were studied, indicating that the
different affinity states detected with BIO1211 are an inherent
property of the integrin.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Chigaev, A. Waller, G. J. Zwartz, T. Buranda, and L. A. Sklar Regulation of Cell Adhesion by Affinity and Conformational Unbending of {alpha}4beta1 Integrin J. Immunol., June 1, 2007; 178(11): 6828 - 6839. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. DiVietro, D. C. Brown, L. A. Sklar, R. S. Larson, and M. B. Lawrence Immobilized Stromal Cell-Derived Factor-1{alpha} Triggers Rapid VLA-4 Affinity Increases to Stabilize Lymphocyte Tethers on VCAM-1 and Subsequently Initiate Firm Adhesion J. Immunol., March 15, 2007; 178(6): 3903 - 3911. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, S. E. Craig, H. Kirby, M. J. Humphries, and V. T. Moy Molecular Basis for the Dynamic Strength of the Integrin {alpha}4{beta}1/VCAM-1 Interaction Biophys. J., November 1, 2004; 87(5): 3470 - 3478. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Zwartz, A. Chigaev, D. C. Dwyer, T. D. Foutz, B. S. Edwards, and L. A. Sklar Real-time Analysis of Very Late Antigen-4 Affinity Modulation by Shear J. Biol. Chem., September 10, 2004; 279(37): 38277 - 38286. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chigaev, G. J. Zwartz, T. Buranda, B. S. Edwards, E. R. Prossnitz, and L. A. Sklar Conformational Regulation of {alpha}4{beta}1-Integrin Affinity by Reducing Agents: "INSIDE-OUT" SIGNALING IS INDEPENDENT OF AND ADDITIVE TO REDUCTION-REGULATED INTEGRIN ACTIVATION J. Biol. Chem., July 30, 2004; 279(31): 32435 - 32443. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vitte, A.-M. Benoliel, P. Eymeric, P. Bongrand, and A. Pierres {beta}-1 Integrin-Mediated Adhesion May Be Initiated by Multiple Incomplete Bonds, Thus Accounting for the Functional Importance of Receptor Clustering Biophys. J., June 1, 2004; 86(6): 4059 - 4074. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Mould, S. J. Barton, J. A. Askari, S. E. Craig, and M. J. Humphries Role of ADMIDAS Cation-binding Site in Ligand Recognition by Integrin {alpha}5{beta}1 J. Biol. Chem., December 19, 2003; 278(51): 51622 - 51629. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Theien, C. L. Vanderlugt, C. Nickerson-Nutter, M. Cornebise, D. M. Scott, S. J. Perper, E. T. Whalley, and S. D. Miller Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE Blood, December 15, 2003; 102(13): 4464 - 4471. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chigaev, T. Buranda, D. C. Dwyer, E. R. Prossnitz, and L. A. Sklar FRET Detection of Cellular {alpha}4-Integrin Conformational Activation Biophys. J., December 1, 2003; 85(6): 3951 - 3962. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chigaev, G. Zwartz, S. W. Graves, D. C. Dwyer, H. Tsuji, T. D. Foutz, B. S. Edwards, E. R. Prossnitz, R. S. Larson, and L. A. Sklar {alpha}4{beta}1 Integrin Affinity Changes Govern Cell Adhesion J. Biol. Chem., October 3, 2003; 278(40): 38174 - 38182. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Egger, J. Cao, C. McCallum, U. Kidambi, G. Van Riper, E. McCauley, R. A. Mumford, T. J. Lanza, L. S. Lin, S. E. de Laszlo, et al. A Small Molecule {alpha}4{beta}1/{alpha}4{beta}7 Antagonist Differentiates between the Low-Affinity States of {alpha}4{beta}1 and {alpha}4{beta}7: Characterization of Divalent Cation Dependence J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 903 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Woodside, A. Obergfell, A. Talapatra, D. A. Calderwood, S. J. Shattil, and M. H. Ginsberg The N-terminal SH2 Domains of Syk and ZAP-70 Mediate Phosphotyrosine-independent Binding to Integrin beta Cytoplasmic Domains J. Biol. Chem., October 11, 2002; 277(42): 39401 - 39408. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Calzada, M. V. Alvarez, and J. Gonzalez-Rodriguez Agonist-specific Structural Rearrangements of Integrin alpha IIbbeta 3. CONFIRMATION OF THE BENT CONFORMATION IN PLATELETS AT REST AND AFTER ACTIVATION J. Biol. Chem., October 11, 2002; 277(42): 39899 - 39908. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Erbe, S. Wang, Y. Xing, and J. F. Tobin Small Molecule Ligands Define a Binding Site on the Immune Regulatory Protein B7.1 J. Biol. Chem., February 22, 2002; 277(9): 7363 - 7368. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Andrews, C. L. Kepley, L. Youssef, B. S. Wilson, and J. M. Oliver Regulation of the very late antigen-4-mediated adhesive activity of normal and nonreleaser basophils: roles for Src, Syk, and phosphatidylinositol 3-kinase J. Leukoc. Biol., November 1, 2001; 70(5): 776 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ding, K. Xiong, and T. B. Issekutz Chemokines stimulate human T lymphocyte transendothelial migration to utilize VLA-4 in addition to LFA-1 J. Leukoc. Biol., March 1, 2001; 69(3): 458 - 466. [Abstract] [Full Text] |
||||
![]() |
S. W. Feigelson, V. Grabovsky, E. Winter, L. L. Chen, R. B. Pepinsky, T. Yednock, D. Yablonski, R. Lobb, and R. Alon The Src Kinase p56lck Up-regulates VLA-4 Integrin Affinity. IMPLICATIONS FOR RAPID SPONTANEOUS AND CHEMOKINE-TRIGGERED T CELL ADHESION TO VCAM-1 AND FIBRONECTIN J. Biol. Chem., April 20, 2001; 276(17): 13891 - 13901. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chigaev, A. M. Blenc, J. V. Braaten, N. Kumaraswamy, C. L. Kepley, R. P. Andrews, J. M. Oliver, B. S. Edwards, E. R. Prossnitz, R. S. Larson, et al. Real Time Analysis of the Affinity Regulation of alpha 4-Integrin. THE PHYSIOLOGICALLY ACTIVATED RECEPTOR IS INTERMEDIATE IN AFFINITY BETWEEN RESTING AND Mn2+ OR ANTIBODY ACTIVATION J. Biol. Chem., December 21, 2001; 276(52): 48670 - 48678. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Chen, A. Whitty, D. Scott, W.-C. Lee, M. Cornebise, S. P. Adams, R. C. Petter, R. R. Lobb, and R. B. Pepinsky Evidence That Ligand and Metal Ion Binding to Integrin alpha 4beta 1 Are Regulated through a Coupled Equilibrium J. Biol. Chem., September 21, 2001; 276(39): 36520 - 36529. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |